Global Initiative for Asthma Strategy 2021. Executive Summary and Rationale for Key Changes

Global Initiative for Asthma Strategy 2021. Executive Summary and Rationale for Key Changes

Show other versions (4)

The Global Initiative for Asthma (GINA) Strategy Report provides clinicians with an annually updated evidence-based strategy for asthma management and prevention, which can be adapted for local circumstances (e.g., medication availability). This article summarizes key recommendations from GINA 2021,...

Full description

Bibliographic Details
Main Authors: Bacharier, L.B (Author), Bateman, E.D (Author), Boulet, L.-P (Author), Brightling, C.E (Author), Brusselle, G.G (Author), Buhl, R. (Author), Cruz, A.A (Author), Drazen, J.M (Author), Duijts, L. (Author), FitzGerald, J.M (Author), Fleming, L.J (Author), Inoue, H. (Author), Ko, F.W (Author), Krishnan, J.A (Author), Levy, M.L (Author), Lin, J. (Author), Mortimer, K. (Author), Pitrez, P.M (Author), Reddel, H.K (Author), Sheikh, A. (Author), Yorgancioglu, A.A (Author)
Format: Article
Language:English
Published: Sociedad Espanola de Neumologia y Cirugia Toracica (SEPAR) 2022
Subjects:
add on therapy
age
allergen
antibiotic agent
asthma
Asthma
Asthma diagnosis
Asthma management
Asthma prevention
avoidance behavior
azithromycin
beta 2 adrenergic receptor stimulating agent
biological product
breast feeding
cigarette smoke
corticosteroid
dexamethasone
disease exacerbation
disease severity
drug use
environmental exposure
evidence based medicine
follow up
formoterol
health care availability
human
information dissemination
low drug dose
lung function
medical assessment
medical decision making
medical research
muscarinic receptor blocking agent
paracetamol
patient care
patient education
practice guideline
prednisolone
prednisone
pregnancy
risk assessment
risk management
self care
Short Survey
symptom
treatment outcome
treatment planning
vitamin D
vitamin D deficiency
Online Access:View Fulltext in Publisher

Internet

View Fulltext in Publisher

Similar Items